Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RNASEL | Q05823 | 4/20 | 0.46 |
| ▸ | P2RY2 | P41231 | 4/20 | 0.45 |
| ▸ | P2RY4 | P51582 | 3/20 | 0.45 |
| ▸ | P2RY12 | Q9H244 | 2/20 | 0.44 |
| ▸ | P2RY14 | Q15391 | 3/20 | 0.43 |
| ▸ | DNPH1 | O43598 | 2/20 | 0.42 |
| ▸ | P2RY6 | Q15077 | 3/20 | 0.41 |
| ▸ | P2RY1 | P47900 | 1/20 | 0.41 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21307917 | 1.00 | RNASEL (0.46) | RNASELP2RY2P2RY4P2RY12P2RY14 | |
| SCHEMBL23625051 | 0.95 | RNASEL (0.45) | RNASELP2RY2P2RY4P2RY12P2RY14 | |
| SCHEMBL26291926 | 0.94 | RNASEL (0.46) | RNASELP2RY2P2RY4P2RY12P2RY14 | |
| SCHEMBL22375442 | 0.94 | RNASEL (0.46) | RNASELP2RY2P2RY4P2RY12P2RY14 | |
| SCHEMBL26294878 | 0.94 | RNASEL (0.46) | RNASELP2RY2P2RY4P2RY12P2RY14 | |
| SCHEMBL23895244 | 0.92 | RNASEL (0.45) | RNASELP2RY2P2RY4P2RY12P2RY14 | |
| SCHEMBL30292621 | 0.91 | RNASEL (0.45) | RNASELP2RY2P2RY4P2RY12P2RY14 | |
| SCHEMBL26442453 | 0.91 | RNASEL (0.45) | RNASELP2RY2P2RY4P2RY12P2RY14 | |
| SCHEMBL20778026 | 0.91 | RNASEL (0.45) | RNASELP2RY2P2RY4P2RY12P2RY14 | |
| SCHEMBL22375444 | 0.91 | RNASEL (0.40) | RNASELP2RY2P2RY4P2RY12P2RY14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2019161171-A1 | NANOPARTICLE FORMULATIONS OF STING AGONISTS | SPEROVIE BIOSCIENCES, INC. (US) | 2019-08-22 | — | — | WO | disclosed |